|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Bioiberica |
|---|---|
| Information provided by: | Bioiberica |
| ClinicalTrials.gov Identifier: | NCT00669123 |
Purpose
The purpouse of this study is to determine the efficacy and safety of chondroitin sulphate conventional treatment in patients with both knee osteoarthritis and plaque psoriasis.
| Condition | Intervention | Phase |
|---|---|---|
|
Osteoarthritis Psoriasis Joint Diseases Muskuloskeletal Diseases Skin Diseases |
Drug: Chondroitin sulphate Drug: Placebo |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | Fase IV Clinical Trial to Evaluate Chondroitin Sulphate Efficacy and Safety in Patients With Knee Osteoarthritis and Psoriasis |
| Enrollment: | 126 |
| Arms | Assigned Interventions |
|---|---|
| 2: Placebo Comparator | Drug: Placebo |
|
1: Experimental
Chondroitin sulphate
|
Drug: Chondroitin sulphate
Chondroitin sulphate 800 mg/day
|
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Spain | |
| Hospital del Mar | |
| Barcelona, Spain, 08003 | |
| Instituto Poal de Reumatología | |
| Barcelona, Spain, 08022 | |
| Principal Investigator: | Pere Benito, MD | Hospital del Mar |
| Principal Investigator: | Montserrat Pérez, MD | Instituto Poal de Reumatología |
| Principal Investigator: | Ingrid Möller, MD | Instituto Poal de Reumatología |
More Information
| Responsible Party: | Bioiberica ( Dr Josep Vergés Milano, Scientific Medical Director ) |
| Study ID Numbers: | CS/IV/PSO/ART |
| Study First Received: | April 24, 2008 |
| Last Updated: | April 28, 2008 |
| ClinicalTrials.gov Identifier: | NCT00669123 History of Changes |
| Health Authority: | Spain: Ministry of Health |
|
Chondroitin sulphate Knee osteoarthritis Psoriasis |
|
Osteoarthritis, Knee Musculoskeletal Diseases Skin Diseases Psoriasis Osteoarthritis |
Arthritis Joint Diseases Rheumatic Diseases Skin Diseases, Papulosquamous |